Masimo's Q3 2025 results showcased an 8% revenue growth and a remarkable 38% year-over-year increase in adjusted earnings per share, bolstered by strong operational efficiencies and strategic milestones.

• Achieved 450 basis points of operating margin expansion fueled by higher revenue and improved cost efficiencies.
• Completed the sale of Sound United, enhancing focus on core healthcare operations.
• Expanded partnership with Philips, indicating significant growth potential in underpenetrated market segments.
• Introduced innovative AI-driven solutions aimed at enhancing patient monitoring and meeting future compliance standards.
• Demonstrated strong clinical results, underscoring the efficacy and accuracy of Masimo's technology across diverse patient demographics.